MR spectroscopy in schizophrenia
- 18 November 2011
- journal article
- review article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 34 (6) , 1251-1261
Abstract
The purpose of this study is to review the MR spectroscopic literature regarding schizophrenia. However, as there are over 250 primary MRS articles and dozens of MRS review articles on the subject already, this study will take a different approach. First, the clinical features of schizophrenia will be described. The background neuroanatomy and biochemistry relevant to schizophrenia will be reviewed, as many readers of this journal are unlikely to be familiar with these fields. A current model of the abnormal neural circuitry in schizophrenia will be presented, and predictions extrapolated about relevant metabolite changes over time. Finally, the existing MRS literature will be reviewed in the context of our existing anatomical and chemical knowledge, and future MRS research directions will be elaborated. J. Magn. Reson. Imaging 2011;.Keywords
This publication has 74 references indexed in Scilit:
- Elevated Gamma-Aminobutyric Acid Levels in Chronic SchizophreniaBiological Psychiatry, 2010
- Assessments of Function and Biochemistry of the Anterior Cingulate Cortex in SchizophreniaBiological Psychiatry, 2010
- Optimized glutamate detection at 3TJournal of Magnetic Resonance Imaging, 2009
- Oral glycine administration increases brain glycine/creatine ratios in men: A proton magnetic resonance spectroscopy studyPsychiatry Research: Neuroimaging, 2009
- Creatine abnormalities in schizophrenia and bipolar disorderPsychiatry Research: Neuroimaging, 2009
- Longitudinal progression of negative symptoms in schizophrenia: A new look at an old problemSchizophrenia Research, 2008
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaTrends in Neurosciences, 2008
- Brain Metabolite Abnormalities in the White Matter of Elderly Schizophrenic Subjects: Implication for Glial DysfunctionBiological Psychiatry, 2007
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorderSchizophrenia Research, 2007